Literature DB >> 3064218

Histiocytoses of lymph nodes: biology and differential diagnosis.

E S Jaffe1.   

Abstract

Two major subsets of histiocytic cells are recognized within the lymphoreticular system: the dendritic cells or antigen-presenting cells and the phagocytic histiocytes or antigen-processing cells. Reactive and proliferative lesions of histiocytes can be related to these functional subsets. Reactive proliferations with a major dendritic cell component include dermatopathic lymphadenitis and Langerhans cell histiocytosis. Rare neoplasms derived from dendritic cells have been described. Benign proliferative lesions of phagocytic histiocytes include sinus histiocytosis with massive lymphadenopathy, the hemophagocytic syndromes including familial erythrophagocytic lymphohistiocytosis, Kikuchi's disease, and the various granulomatous lesions of lymph nodes. Although the hemophagocytic syndromes were often interpreted in the past as a variant of malignant histiocytosis (histiocytic medullary reticulosis), the reactive nature of this process is now accepted. The inciting event is usually an infection, and it is hypothesized that the histiocytic proliferation may result from exaggerated lymphokine production in an immunocompromised host. Reactive lesions of histiocytes are much more common than their rare neoplastic counterparts. True histiocytic lymphomas must be distinguished from the more common sinusoidal large cell immunoblastic lymphomas which usually express the CD30 antigen.

Entities:  

Mesh:

Year:  1988        PMID: 3064218

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  5 in total

Review 1.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).

Authors:  W H McAlister; T Herman; L P Dehner
Journal:  Pediatr Radiol       Date:  1990

2.  Development of an Orthotopic Intrasplenic Xenograft Mouse Model of Canine Histiocytic Sarcoma and Its Use in Evaluating the Efficacy of Treatment with Dasatinib.

Authors:  Marilia Takada; Lauren A Smyth; Jeremy Ml Hix; Sarah M Corner; Matti Kiupel; Vilma Yuzbasiyan-Gurkan
Journal:  Comp Med       Date:  2019-02-04       Impact factor: 0.982

3.  A 26-year-old man with Hodgkin's disease and rapidly progressive pancytopenia.

Authors:  J C Kluin-Nelemans; P M Kluin; R Bieger
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

4.  Histiocytic sarcoma with acute lymphoblastic leukemia a rare association: case report and literature review.

Authors:  Abhijeet P Ganapule; Mayank Gupta; Gautami Kokil; Auro Viswabandya
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-04       Impact factor: 0.900

5.  A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies.

Authors:  Marilia Takada; Maciej Parys; Emmalena Gregory-Bryson; Paulo Vilar Saavedra; Matti Kiupel; Vilma Yuzbasiyan-Gurkan
Journal:  BMC Cancer       Date:  2018-03-01       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.